• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双倍时间的光动力疗法治疗局限性脉络膜血管瘤:基于初始参数的功能和解剖结果。

Photodynamic therapy with double duration for circumscribed choroidal haemangioma: functional and anatomical results based on initial parameters.

机构信息

Department of Ophthalmology, Eberhard Karls University Tübingen, Tübingen, Germany.

出版信息

Clin Exp Ophthalmol. 2018 Jul;46(5):495-501. doi: 10.1111/ceo.13096. Epub 2017 Dec 6.

DOI:10.1111/ceo.13096
PMID:29131474
Abstract

IMPORTANCE

Pre-treatment symptoms longer than 12 months and foveal cystoid changes are indicators for poor anatomical and functional outcome after photodynamic therapy (PDT).

BACKGROUND

To evaluate the prognostic factors on the effectiveness of PDT with double duration for treatment of exudative circumscribed choroidal haemangioma.

DESIGN

Retrospective study.

PARTICIPANTS

Twenty-seven patients with symptomatic exudative circumscribed choroidal haemangioma treated with PDT.

METHODS

Clinical charts of patients with exudative circumscribed choroidal haemangioma treated with PDT were analysed with regard to visual acuity, duration of symptoms, subfoveal fluid, foveal cystoid changes and foveal thickness in optical coherence tomography.

MAIN OUTCOME MEASURES

Change of best-corrected visual acuity, sub- and intrafoveal fluid and foveal thickness measured with optical coherence tomography from baseline to last follow-up.

RESULTS

Mean visual acuity improved by 0.05 from 0.42 logMAR (standard deviation [SD] 0.34) to 0.37 logMAR (SD 0.47). In 70% of the patients, PDT stopped exudation and revealed a dry fovea. The recurrence or persistence of sub- or intrafoveal fluid was significantly associated with pre-therapeutic symptoms existing for more than 12 months (P = 0.046). Mean foveal thickness in optical coherence tomography decreased from 324 μm (SD 223 μm) to 209 μm (SD 109 μm).

CONCLUSIONS AND RELEVANCE

PDT proved to be a safe and effective treatment procedure for exudative circumscribed choroidal haemangioma in our series, with few side effects. We observed a more successful treatment with regard to anatomical and functional results in cases with pre-existing symptoms less than 12 months and in cases without pre-therapeutic foveal cystoid changes.

摘要

重要性

治疗前症状超过 12 个月和中心凹囊样改变是光动力疗法(PDT)后解剖和功能结局不良的指标。

背景

评估 PDT 双剂量治疗渗出性局限性脉络膜血管瘤的有效性的预后因素。

设计

回顾性研究。

参与者

27 例有症状的渗出性局限性脉络膜血管瘤患者接受 PDT 治疗。

方法

分析有渗出性局限性脉络膜血管瘤患者的临床病历,分析视力、症状持续时间、黄斑下积液、中心凹囊样改变和光学相干断层扫描(OCT)中的中心凹厚度。

主要观察指标

从基线到最后一次随访时最佳矫正视力、黄斑下和中心凹积液以及 OCT 测量的中心凹厚度的变化。

结果

平均视力从 0.42 对数视力(标准差[SD]0.34)提高到 0.37 对数视力(SD 0.47),提高了 0.05。在 70%的患者中,PDT 停止了渗出,并显示出干性黄斑。黄斑下或中心凹积液的复发或持续与治疗前存在超过 12 个月的症状(P=0.046)显著相关。OCT 测量的平均中心凹厚度从 324μm(SD 223μm)下降到 209μm(SD 109μm)。

结论

在我们的研究中,PDT 被证明是治疗渗出性局限性脉络膜血管瘤的一种安全有效的治疗方法,副作用较少。我们观察到,对于治疗前症状少于 12 个月和治疗前没有中心凹囊样改变的病例,在解剖和功能结果方面,治疗效果更为成功。

相似文献

1
Photodynamic therapy with double duration for circumscribed choroidal haemangioma: functional and anatomical results based on initial parameters.双倍时间的光动力疗法治疗局限性脉络膜血管瘤:基于初始参数的功能和解剖结果。
Clin Exp Ophthalmol. 2018 Jul;46(5):495-501. doi: 10.1111/ceo.13096. Epub 2017 Dec 6.
2
Photodynamic Therapy for Circumscribed Choroidal Hemangioma in 79 Consecutive Patients: Comparative Analysis of Factors Predictive of Visual Outcome.79 例局限性脉络膜血管瘤的光动力疗法:预测视力结果的因素比较分析。
Ophthalmol Retina. 2020 Oct;4(10):1024-1033. doi: 10.1016/j.oret.2020.04.018. Epub 2020 Apr 25.
3
High recurrence rate in patients with choroidal hemangioma treated with limited single spot photodynamic therapy during long-term follow-up.在长期随访中,接受有限单部位光动力疗法治疗的脉络膜血管瘤患者复发率高。
Acta Ophthalmol. 2020 Nov;98(7):679-686. doi: 10.1111/aos.14409. Epub 2020 Apr 14.
4
Circumscribed Choroidal Hemangioma: Visual Outcome in the Pre-Photodynamic Therapy Era versus Photodynamic Therapy Era in 458 Cases.局限性脉络膜血管瘤:458 例患者在光动力疗法前时代与光动力疗法时代的视力结局。
Ophthalmol Retina. 2020 Jan;4(1):100-110. doi: 10.1016/j.oret.2019.08.004. Epub 2019 Aug 22.
5
Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes.光动力疗法联合维替泊芬治疗症状性局限性脉络膜血管瘤:五年随访结果。
Ophthalmology. 2010 Aug;117(8):1630-7. doi: 10.1016/j.ophtha.2009.12.033. Epub 2010 Apr 24.
6
Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma.使用维替泊芬治疗局限性脉络膜血管瘤的光动力疗法。
Br J Ophthalmol. 2003 Jan;87(1):84-9. doi: 10.1136/bjo.87.1.84.
7
Photodynamic therapy for symptomatic circumscribed choroidal hemangioma in 22 Chinese patients: A retrospective study.22 例中国患者症状性局限性脉络膜血管瘤的光动力疗法:回顾性研究。
Photodiagnosis Photodyn Ther. 2018 Dec;24:372-376. doi: 10.1016/j.pdpdt.2018.10.019. Epub 2018 Oct 28.
8
Optical coherence tomography for evaluation of photodynamic therapy in symptomatic circumscribed choroidal hemangioma.光学相干断层扫描在症状性局限性脉络膜血管瘤光动力疗法中的评估。
Retina. 2011 Feb;31(2):336-43. doi: 10.1097/IAE.0b013e3181e79887.
9
COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.局限型脉络膜血管瘤中质子束与光动力疗法对视功能保护的疗效比较。
Retina. 2021 Feb 1;41(2):277-286. doi: 10.1097/IAE.0000000000002843.
10
EFFICACY OF DOUBLE DOSE PHOTODYNAMIC THERAPY FOR CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.双倍剂量光动力疗法治疗局限性脉络膜血管瘤的疗效。
Retina. 2019 Feb;39(2):392-397. doi: 10.1097/IAE.0000000000001967.

引用本文的文献

1
New insights on circumscribed choroidal hemangioma: "bench to bedside".局限性脉络膜血管瘤的新认识:“从基础到临床”。
Graefes Arch Clin Exp Ophthalmol. 2024 Apr;262(4):1093-1110. doi: 10.1007/s00417-023-06179-x. Epub 2023 Jul 28.
2
[Incidentally detected small subretinal tumor].
Ophthalmologie. 2023 Oct;120(10):1053-1055. doi: 10.1007/s00347-023-01892-8. Epub 2023 Jul 6.
3
Photodynamic Therapy for Treatment of Disease in Children-A Review of the Literature.儿童疾病的光动力治疗——文献综述
Children (Basel). 2022 May 10;9(5):695. doi: 10.3390/children9050695.